Tampa, FL, United States of America

Donghwa Kim

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: University of South Florida, Florida International University, Rutgers, The State University of New Jersey. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donghwa Kim. Retrieved from https://idiyas.com/inventor/donghwa-kim-77nl5ge0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Donghwa Kim

Introduction

Donghwa Kim is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of medicine, particularly in the treatment of obstructive lung diseases. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is focused on bronchodilators for treating obstructive lung disease. The compounds disclosed in this patent are TAS2Rs agonists, which may also be used to treat disorders and conditions associated with TAS2R. In some instances, these compounds can be utilized in the treatment of asthma. Another significant patent involves biased adrenergic agonists. This patent outlines compounds, compositions, and methods for selectively targeting βAR receptors, which may be beneficial in treating obstructive lung diseases.

Career Highlights

Donghwa Kim has worked with prestigious institutions such as the University of South Florida and Rutgers, the State University of New Jersey. His research and innovations have garnered attention in the medical community.

Collaborations

He has collaborated with notable individuals in his field, including Stephen Bryant Liggett and James William Leahy. Their combined expertise has contributed to advancements in respiratory treatments.

Conclusion

Donghwa Kim's work in developing innovative treatments for obstructive lung diseases showcases his dedication to improving healthcare. His patents reflect a commitment to addressing significant medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…